Endothelins: A Potential Target for Pharmacological Intervention in Diseases of the Elderly

Drugs & Aging

Volumn 4, Issue 3, 1994, Pages 221-237

  Lévesque, Hervé ^a   Moore, Nicholas ^a   Cailleux, Nicole ^a   Richard, Vincent ^a   Thuillez, Christian ^a   Courtois, Hubert ^a  

^a Dept de Médecine Interne Ctr Hosp Univ Rouen Boisguillaume   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN;

AGED; AGING; AMINO ACID SEQUENCE; ARTICLE; CARDIOVASCULAR DISEASE; HUMAN; MOLECULAR GENETICS; PHYSIOLOGY;

AGED; AGING; AMINO ACID SEQUENCE; CARDIOVASCULAR DISEASES; ENDOTHELINS; HUMAN; MOLECULAR SEQUENCE DATA;

EID: 0028384703     PISSN: 1170229X     EISSN: 11791969     Source Type: Journal    
DOI: 10.2165/00002512-199404030-00005     Document Type: Review

References (160)

1. Role of NEP in the metabolism of endothelin
2. Circulating immunoreactive endothelin-1 in children with pulmonary hypertension
3. Endothelin-1 mediated vasoconstriction: specific blockade by verapamil
4. Cloning an expression of a cDNA encoding an endothelin receptor
5. Increased plasma endothelin in patients with hyperlipoproteinemia and stable and unstable angina
6. Chromosomal assignments of the human endothelin family genes: the endothelin-1 gene (EDN1) to 6p-3p24, the endothelin-2 gene (EDN2) to 1p34, and the endothelin 3 gene (EDN3) to 20q13.2-q13.3
7. Endothelin and the production of cerebral vasospasm in dogs
8. Mesangial cell, glomerular and renal vascular responses to endothelin in the rat kidney
9. Endothelins: circulating plasma levels and presence in other biologic fluids
10. Potent thromboxane-mediated in vitro bronchoconstrictor effect of endothelin in the guinea-pig
11. cDNA cloning and chromosomal assignment of the gene encoding endothelin-3
12. Structural organization and chromosomal assignment of the gene encoding endothelin
13. BQ123, and ETA receptor antagonist, attenuates endothelin-1 induced vasoconstriction in rat pulmonary circulation
14. Release of endothelin from the porcine aorta; inhibition by endothelium-derived nitric oxide
15. Oxidized low-density lipoproteins induce mRNA expression and release of endothelin from the human and porcine endothelium
16. Effect of endothelin-1 on blood pressure and bronchopulmonary system of the guinea pig
17. In vitro characterization of Ro 46-2005, a novel synthetic non-peptide endothelin antagonist of ETA and ETB receptors
18. Transforming growth factor-13: role in mediating serum-induced endothelin production by vascular endothelial cells
19. Deficiency of calcitonin gene related peptide in Raynaud’s phenomenom
20. Endothelin-1 in primary pulmonary hypertension and the Eisenmenger syndrome
21. Release of substance P from rat hypothalamus and pituitary by endothelin
22. Immunoreactive endothelin in human plasma: marked elevations in patients with cardiogenic shock
23. Endothelin, vasoconstriction, and endothelial damage in Raynaud’s phenomenom
24. Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist
25. Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic heart failure
26. Plasma endothelin-like immunoreactivity levels in IDDM patients with microalbuminuria
27. Physiological importance of nitric oxide. An endogenous vasodilatator
28. Endothelin-1 potentialisation of angiotensin II stimulation of aldosterone production
29. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor
30. Cellular mechanisms of endothelin-1 release by angiotensin and vasopressin
31. Specific receptors for endothelin-3 in cultured bovine endothelial cells and its cellular mechanism of action
32. Lethal ischemia due to intracoronary endothelin in pigs
33. Inhibition of biological actions of big endothelin-1 by phosphoramidon
34. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine
35. Endothelin antiserum decreases volume-stimulated and basal plasma concentration of atrial natriuretic peptide
36. Cardiovascular, renal and endocrine responses to intravenous endothelin in conscious dogs
37. 2+ channel in vascular smooth muscle cells
38. Endotoxin stimulates endothelin release in vivo and in vitro as determined by radioimmunoassay
39. Endothelin enhances delayed potassium current via phospholipase C in guinea pig ventricular myocytes
40. Endothelin is a potent mitogen for rat vascular smooth muscle cells
41. Plasma endothelin-1 levels in idiopathic dilated cardiomyopathy
42. Distinct tissue distribution and cellular localization of two messenger ribonucleic acids encoding different subtypes of rat endothelin receptors
43. Increased plasma immunoreactive endothelin-1 concentration in hypercholesterolemic rats
44. Atrial natriuretic peptide inhibits the production and the secretion of endothelium from cultured endothelial cells
45. A) antagonist isolated from Streptomyces misakiensis
46. Biological profiles of highly potent novel potent endothelin antagonists selective for ETA receptor
47. B) receptors
48. Induction of endothelin-1 gene by angiotensin II and vasopressine in endothelial cells
49. The human endothelins family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes
50. The human prepro-endothelin-1 gene
51. Positive inotropic action of novel vasoconstrictor peptide endothelin on guinea pig atria
52. A novel endothelin ETA receptor antagonist, BQ-485, and its preventive effect on experimental cerebral vasospasm in dogs
53. Cloning and sequence analysis of cDNA encoding the precursor of a human endothelium-derived vasoconstrictor peptide, endothelin: identity of human and porcine endothelin
54. Plasma endothelin-1 levels in patients with diabetes mellitus with or without vascular complication
55. Glucocorticoids induce endothelin release from vascular smooth muscle cells but not endothelial cells
56. The effects of endothelins on secretion of prolactin, luteinizing hormone and follicle-stimulating hormone are mediated by different guanine nucleotide-binding proteins
57. Cloning and characterization or an endothelin-3 specific receptor (ETc receptor) from Xenopus laevis dermal melanophores
58. Effect of aging on endothelin induced prostaglandin 12 release in isolated hind legs of the spontaneously hypertensive rats
59. Increased plasma endothelin in NIDDM patients with retinopathy
60. Atrial and brain natriuretic peptides inhibit the endothelin-1 secretory response to angiotensin-II in porcine aorta
61. Reversal of endothelin-1 induced vasoconstriction by nifedipine in human resistance vessels in vivo in healthy subjects
62. Endothelium-dependent vasodilatation in patients with heart failure
63. Sarafotoxin, a novel vasoconstrictor peptide: phosphoinositide hydrolysis in rat heart and brain
64. Similarities in mode and sites of action of sarafotoxins and endothelins
65. Endothelial regulation of wall shear stress and blood flow in skeletal muscle microcirculation
66. Glomerular actions of endothelin in vivo
67. Autoradiographic distribution in rat tissues of binding-sites for endothelin: a neuropeptide?
68. Hypoxia induces endothelin gene expression and secretion in cultured human endothelium
69. Plasma endothelin levels in patients with uraemia
70. The mechanisms of hypertension and the role of ACE inhibitors
71. Endothelin: a potent vasoconstrictor associated with coronary vasospasm
72. Transforming growth factor B stimulates the expression of endothelin mRNA by vascular endothelial cells
73. Effects of endothelin receptor antagonist on cyclosporin-induced vasoconstriction in isolated rat renal arterioles
74. Vasodilatator activity of endothelin-1 and endothelin-3: rapid development of crosstachyphylaxis and dependance on the rate of endothelin administration
75. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis
76. Circulating and tissue endothelin immunoreactivity in hypercholesterolaemic pigs
77. Effects of endothelin on hyaluronan production by human fetal fibroblasts in culture
78. Les endothelines: une nouvelle classe de peptides vasoactifs
79. Raised plasma endothelin in aneurysmal subarachnoid haemorrhage
80. Cloning and functional expression of a vascular smooth muscle endothelin-1 receptor
81. Adrenoreceptors in Raynaud’s disease
82. Activation of multiple mechanisms including phospholipase D by endothelin-1 in rat aorta
83. Endothelium-derived relaxing and contracting factors: perspectives in nephrology
84. Interactions between endothelium-derived relaxing and contracting factors in health and cardiovascular disease
85. L-arginine in the clinical arena: tool or remedy? Editorial
86. Molecular and cellular biology of endothelin and its receptors
87. Age, hypertension and hypercholesterolaemia alter endothelium-dependent vascular regulation
88. Endothelins: homeostatic and compensatory actions in the circulatory and endocrine sytems
89. Overview: reduced sensitivity of vascular response to endothelin
90. Physiology and pharmacology of endothelins
91. Raised plasma endothelin in subarachnoid haemorrhage
92. Phosphoramidon, a metalloproteinase inhibitor, suppresses the hypertensive effects of big endothelin-1
93. The mechanisms of action of endothelin in human lungs
94. Phosphoramidon blocks the pressor activity of porcine big endothelin-1 in vivo and conversion of big endothelin-1 to endothelin-1
95. Integrated cardiac renal and endocrine actions of endothelin
96. Endothelin-1 and endothelin-3 play different roles in acute and chronic alterations of blood pressure in patients with chronic hemodialysis
97. Age and sex-related variation of plasma endothelin-1 concentration in normal and hypertensive patients
98. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation
99. Endothelin is a positive inotropic agent in human and rat heart
100. Captopril prevents chronic hypertension produced by infusion of endothelin-1 in rats
101. Sequential release of tumor necrosis factor, platelet activiting factor and eicosanoids during endotoxin shock in anaesthetized pigs; protective effects of indomethacin
102. 1,3,11,15] ET-1
103. Elevation of plasma endothelin concentrations during endotoxic shock in dogs
104. Plasma immunoreactive endothelin but not thrombomodulin is increased in essential hypertension and ischemic heart diseases
105. Molecular form of immunoreactive endothelin in plasma and urine of normal patients with various diseases states
106. Phosphoramidon prevents cerebral vasospasm following subarachnoid haemorrhage in dogs: the relationship to endothelin-1 levels in the cerebrospinal fluid
107. The molecular basis for use of calcium antagonists in ischaemic heart disease
108. Endothelin-1 mRNA is widely expressed in porcine and human tissues
109. Endothelial cells in culture produce a vasoconstrictive substance
110. Specific expression of human endothelin 2 (ET-2) gene in a renal adenocarcinoma cell line. Molecular cloning of cDNA encoding the precursor of ET-2 and its characterization
111. Conversion of big endothelin 1 by membrane-bound methalloendopeptidase in cultured bovine endothelial cells
112. Stimulation of endothelin-1 gene expression by insulin in endothelial cell
113. Endothelin-converting enzymes
114. Changes in plasma renin activity and aldosterone concentration in response to endothelin injections in dogs
115. Endothelin activates the vascular renin angiotensin system in rat mesenteric arteries
116. Vascular endothelial cells synthesize nitric oxide from L-arginine
117. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
118. Elevated plasma endothelin-1 concentrations are associated with the severity of illness in patients with sepsis
119. Endothelin stimulates chloride secretion across canine tracheal epithelium
120. Endothelins in the control of cardiovascular and renal function
121. Activation of phospholipase A2 by endothelin in cultured vascular smooth muscle cells
122. Endothelin enhances adrenocorticotropin-stimulated aldosterone release from cultured bovine adrenal cells
123. Ro 47-0203, a new endothelin receptor antagonist, reverses chronic vasospasm in experimental subarachnoid hemorrhage
124. cDNA cloning, sequence analysis and tissue distribution of rat preproendothelin-1 mRNA
125. Molecular characterization of endothelins receptors
126. Cloning of a cDNA encoding of a non-isopeptide-selective subtype of the endothelin receptor
127. Plasma endothelin in human essential hypertension
128. 1,3,11,151]Endothelin-1 analogs with ETB agonistic activity
129. Plasma endothelin levels in hypertension and chronic renal failure
130. Prevention of cerebral vasospasm by actinomycin D
131. Acute pulmonary alveolar hypoxia increases lung and plasma endothelin-1 levels in conscious rats
132. + exchange, c-fos expression and mitogenesis in rat mesangial cells
133. Endothelin-1 in patients with Raynaud’s phenomenon!
134. Endothelin stimulates release of atrial natriuretic peptide in vitro and in vivo
135. Elevated endothelin-1 in heart failure and loss of normal response to postural change
136. Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease
137. The role of endothelin-1 in the origin of cerebral vasospasm in patients with aneurysmal subarachnoid haemorrhage
138. Endothelin immunoreactivity in cerebrospinal fluid of patients with subarachnoid haemorrhage
139. Elevated plasma endothelin in patients with diabetes mellitus
140. Increased plasma level of endothelin-1 and coronary spasm induction in patients with vasospactic angina pectoris
141. Plasma endothelin levels in patients with acute renal failure
142. Modulation of vascular smooth muscle contraction by endothelium
143. Effect of endothelin-1 in man
144. + exchange in brain capillary endothelial cells via a high affinity endothelin-3 receptor that is not coupled to phospholipase C
145. Elevated plasma levels of endothelin in patients with sepsis syndrome
146. The endothelin explosion: a pathophysiological reality or a biological curiosity
147. Hypertension associated with endothelin-secreting malignant hemangioendothelioma
148. Pathophysiological role of endothelin in renal transplantation
149. A novel potent vasoconstrictor peptide produced by vascular endothelial cells
150. Biochemistry and molecular biology of endothelins
151. Endothelin converting enzyme and its in vitro and in vivo inhibition
152. Circulating immunoreactive endothelin in ischemic heart desease
153. Antihypertensive effects of captopril and enalapril in endothelin-infused rats
154. Plasma endothelin concentrations in plasma with pulmonary hypertension associated with congenital heart defects. Evidence for increased production of endothelin in pulmonary circulation
155. Endothelin: a novel peptide in the posterior pituitary system
156. Interleukin 1 increases the production of endothelin-1 release cultured endothelial cells
157. Stimulation of tyrosine kinase activity in anti-phosphotyrosine immune complex of Swiss 3T3 cell lysates occurs rapidly after addition of bombesin, vasopressin, and endothelin to intact cells
158. Serum endothelin-1 concentrations and cold provocation in primary Raynaud’s phenomenon!
159. + — ATPase in intact renal tubular epithelial cells
160. Endothelin stimulates aldosterone secretion in vitro from normal adrenocortical tissue, but not adenoma tissue in primary aldosteronism